WallStreetZenWallStreetZen

AnalystsChris Shibutani
Chris Shibutani's Stock Forecasts

Analyst Ranking
Top 18%
#768 out of 4476 analysts
Average Return
+13.26%
Win Rate
50%20 out of 40
Risk vs Reward
Poor
Good

Chris Shibutani's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Prometheus Biosciences IncRXDX
+486.79%$34.07$199.92
2022-07-19 -
2023-06-15
Strong Buy
Mirati Therapeutics IncMRTX
+117.30%$16.65$36.18
2017-12-20 -
2018-12-21
Buy
Nektar TherapeuticsNKTR
+79.26%$4.74$0.98
2022-04-17 -
2023-04-17
Strong Sell
Prometheus Biosciences IncRXDX
+75.89%$113.66$199.92
2023-01-30 -
2023-06-15
Strong Buy
Syndax Pharmaceuticals IncSNDX
+72.83%$13.14$22.71
2023-10-10 -
2024-02-22
Strong Buy

Chris Shibutani's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Royalty Pharma PLCRPRX
2Strong Buy$50.00+61.19%Maintains
3 days ago
Organon & CoOGN
3Hold$18.00-2.96%Maintains
3 days ago
United Therapeutics CorpUTHR
2Hold$215.00-1.19%Upgrades
11 days ago
Neurocrine Biosciences IncNBIX
2Strong Buy$153.00+14.72%Maintains
a month ago
Revance Therapeutics IncRVNC
3Hold$8.00+50.66%Downgrades
a month ago
Abbvie IncABBV
3Strong Buy$173.00-2.12%Upgrades
2 months ago
Amylyx Pharmaceuticals IncAMLX
6Strong Buy$40.00+115.75%Maintains
3 months ago
Seres Therapeutics IncMCRB
2Strong Sell$1.25+13.64%Maintains
4 months ago
Bristol Myers Squibb CoBMY
2Strong Buy$69.00+34.42%Maintains
4 months ago
Syndax Pharmaceuticals IncSNDX
2Strong Buy$30.00+32.10%Initiates Coverage On
4 months ago
Eli Lilly & CoLLY
4Hold$470.00-38.93%Maintains
6 months ago
Erasca IncERAS
2Strong Buy$9.00+354.55%Maintains
9 months ago
Eqrx IncEQRX
3Hold$3.00+28.21%Maintains
9 months ago
Biontech SeBNTX
4Hold$140.00+49.62%Maintains
a year ago
Innoviva IncINVA
2Hold$13.00-16.02%Maintains
a year ago
Revolution Medicines IncRVMD
3Hold$23.00-20.83%Maintains
a year ago
Nektar TherapeuticsNKTR
3Strong Sell$2.00+202.57%Maintains
a year ago
Prometheus Biosciences IncRXDX
2Strong Buy$144.00N/AMaintains
a year ago
Ventyx Biosciences IncVTYX
1Strong Buy$50.00N/AInitiates Coverage On
a year ago
Kymera Therapeutics IncKYMR
2Strong Buy$52.00N/AMaintains
a year ago
Pfizer IncPFE
2Strong Buy$60.00N/AUpgrades
a year ago
Entrada Therapeutics IncTRDA
3Hold$18.00N/AMaintains
a year ago
Alkermes PLCALKS
1Strong Buy$35.00N/AInitiates Coverage On
2 years ago
Johnson & JohnsonJNJ
1Hold$161.00N/AInitiates Coverage On
2 years ago
Exscientia PLCEXAI
1Strong Buy$30.00N/AInitiates Coverage On
2 years ago
Tango Therapeutics IncTNGX
1Strong Buy$17.00N/AInitiates Coverage On
2 years ago
Arena Pharmaceuticals IncARNA
1Strong Buy$90.00N/AInitiates Coverage On
3 years ago
Repare Therapeutics IncRPTX
1BuyN/AN/AInitiates Coverage On
4 years ago
Ardelyx IncARDX
1BuyN/AN/AInitiates Coverage On
4 years ago
Puma Biotechnology IncPBYI
2HoldN/AN/ADowngrades
6 years ago
Mirati Therapeutics IncMRTX
1BuyN/AN/AInitiates Coverage On
6 years ago
Radius Health IncRDUS1
1HoldN/AN/ADowngrades
7 years ago
Five Prime Therapeutics IncFPRX
1BuyN/AN/AInitiates Coverage On
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.